| Dr Cindy Qingxin Shi, MD PHD | |
|
35 Monument Rd, Suite 201, York, PA 17403-5074 | |
| (717) 812-4083 | |
| (717) 812-2244 |
| Full Name | Dr Cindy Qingxin Shi |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 35 Monument Rd, York, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053307959 | NPI | - | NPPES |
| 20069119 | Other | PA | AMERIHEALTH MERCY-WMG |
| 1521051 | Other | PA | GATEWAY WMG |
| 50074896 | Other | PA | CAPITAL BLUE CROSS-WMG |
| 235931 | Other | PA | UNISON-WMG |
| 212046 | Other | PA | JOHNS HOPKINS |
| 718401800 | Medicaid | MD | |
| 589786 | Other | PA | HIGHMARK BLUE SHIELD |
| 919374 | Other | MD | CAREFIRST MD BCBS |
| 001755235 | Medicaid | PA | |
| 7243064 | Other | PA | AETNA |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellspan Medical Group | 1951213115 | 1946 |
News Archive
TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.
Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made a breakthrough in understanding an important protein that appears to act as a kind of cellular "marriage broker."
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services unit has formed a research collaboration with Denver-based Catholic Health Initiatives, one of the nation's largest health systems.
Many people may think of whooping cough as a disease of the past - something eradicated generations ago. However, the number of cases reported by the Centers for Disease Control and Prevention (CDC) indicate that whooping cough (pertussis) is still very much a public health concern; health experts estimate that up to 600,000 cases occur each year in adults alone. In fact, whooping cough cases are on the rise in San Diego
› Verified 6 days ago
| Entity Name | Wellspan Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750480299 PECOS PAC ID: 1951213115 Enrollment ID: O20040220000815 |
News Archive
TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.
Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made a breakthrough in understanding an important protein that appears to act as a kind of cellular "marriage broker."
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services unit has formed a research collaboration with Denver-based Catholic Health Initiatives, one of the nation's largest health systems.
Many people may think of whooping cough as a disease of the past - something eradicated generations ago. However, the number of cases reported by the Centers for Disease Control and Prevention (CDC) indicate that whooping cough (pertussis) is still very much a public health concern; health experts estimate that up to 600,000 cases occur each year in adults alone. In fact, whooping cough cases are on the rise in San Diego
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Cindy Qingxin Shi, MD PHD 1803 Mount Rose Ave, Suite B2, York, PA 17403-3026 Ph: (717) 851-1405 | Dr Cindy Qingxin Shi, MD PHD 35 Monument Rd, Suite 201, York, PA 17403-5074 Ph: (717) 812-4083 |
News Archive
TWi Pharmaceuticals, Inc. today announced that it has received tentative approval for its Abbreviated New Drug Application for Guanfacine Hydrochloride Extended Release Tablets 1mg, 2mg, 3mg and 4mg from the United States Food and Drug Administration.
Scientists at the Montreal Neurological Institute and Hospital -The Neuro, at McGill University and the McGill University Health Centre, have made a breakthrough in understanding an important protein that appears to act as a kind of cellular "marriage broker."
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase (PI3K) inhibitors for the treatment of cancer and inflammatory diseases, today announced it has closed a $40 million Series C financing. The financing was led by Quogue Capital, LLC along with existing investors Alta Partners, Amgen Ventures, Frazier Healthcare and Three Arch Partners and new investor Latterell Venture Partners.
Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life-sciences research, today announced that its Caliper Discovery Alliances and Services unit has formed a research collaboration with Denver-based Catholic Health Initiatives, one of the nation's largest health systems.
Many people may think of whooping cough as a disease of the past - something eradicated generations ago. However, the number of cases reported by the Centers for Disease Control and Prevention (CDC) indicate that whooping cough (pertussis) is still very much a public health concern; health experts estimate that up to 600,000 cases occur each year in adults alone. In fact, whooping cough cases are on the rise in San Diego
› Verified 6 days ago
Courtney Erin Krug, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 35 Monument Rd Ste 201, York, PA 17403 Phone: 717-812-4083 Fax: 717-812-2244 | |
Ori Shokek, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 25 Monument Rd, Suite 94, York, PA 17403 Phone: 717-741-8180 Fax: 717-741-8196 | |
Reena Kamath Pramanik, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 35 Monument Rd, Suite 201, York, PA 17403 Phone: 717-812-3712 Fax: 717-812-2244 | |
Dr. Douglas E Barnes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 35 Monument Rd, Ste 201, York, PA 17403 Phone: 717-812-4083 Fax: 717-812-2244 | |
Beatrix Astrid Olofsson, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 35 Monument Rd, Suite 201, York, PA 17403 Phone: 717-812-4083 Fax: 717-812-2244 | |
Nora E Dajani, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 35 Monument Rd Ste 201, York, PA 17403 Phone: 717-812-4083 Fax: 717-812-2244 |